New in the description of anaplastic lymphoma on breast implants!

Publication in the January issue of the journal Blood of an article co-authored by members of Nicolas Ortonne’s team in collaboration with teams from Toulouse, among others, describing for the first time the mutational landscape – notably involving activation of the JAK-STAT pathway and disruption of the epigenetic – of a new form of lymphoma, recognized by the FDA in 2010, anaplastic lymphoma on breast implants (breast prostheses).

Blood, January 30, 2020, Vol 135, No. 5, pages 360-370.

For more information : Philippe Gaulard